BOSTON (Reuters) - The drug-mixing company at the heart of a deadly U.S. meningitis outbreak solicited bulk orders from physicians and failed to require proof of individual patient prescriptions as required under state regulations, emails to a customer show.
Reuters reviewed more than a dozen emails that show the New England Compounding Center, contrary to Massachusetts regulations, sold drugs without requiring physicians to supply individual patient prescriptions.The customer confirmed that NECC supplied the clinic with drugs without patient names or prescriptions. http://www.courant.com/health/connecticut/sns-rt-us-usa-health-meningitis-pharmacybre89c056-20121013,0,7463415.story?